DexCom (DXCM) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.48 +0.75%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.12 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.6-4.625 billion, versus the consensus of $4.611 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- JPMorgan Upgrades FOX Corp. (FOXA) to Overweight
- JPMorgan Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
